Reports for Amyra Biotech AG
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
About Amyra Biotech AG
- Amyra Biotech AG is a Company limited by shares (AG) with its legal headquarters in Basel. Amyra Biotech AG belongs to the industry «Research and development» and is currently active.
- The management of the company Amyra Biotech AG consists of 6 persons. The foundation of the company took place on 15.03.2013.
- The commercial register entry of the company was last modified on 14.07.2025. Under «Notifications» it is possible to view all previous changes.
- In the commercial register the company Amyra Biotech AG is registered under the UID CHE-321.956.288.
- There are 7 other active companies that have registered an identical address. These include: Allcon AG, Bests AG, CanVirex AG.
Management (6)
newest board members
Douglas C. Günthardt,
Dr. Werner Tschollar,
Dr. Thomas Zehnder
newest authorized signatories
Julian Tschollar,
Sulayman Mourabit,
Douglas C. Günthardt,
Marcel Charles Gremaud,
Dr. Werner Tschollar
Commercial register information
Entry in the commercial register
15.03.2013
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Basel
Commercial Registry Office
BS
Commercial register number
CH-170.3.037.708-6
UID/VAT
CHE-321.956.288
Sector
Research and development
Purpose (Original language)
Forschung, Entwicklung, Fabrikation und Vertrieb im Bereich von pharmazeutischen, medizinischen, biotechnologischen und verwandten Produkten sowie Erbringung von damit im Zusammenhang stehenden Dienstleistungen; vollständige Zweckumschreibung gemäss Statuten.
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| Ernst & Young AG | Basel | 11.07.2017 | ||
Former auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| Caminada Revisions AG | Zug | 23.12.2014 | 10.07.2017 | |
Other company names
Es sind keine früheren oder übersetzten Firmannamen vorhanden.
Would you like to update the company name? Click here.Branches (0)
Ownership structure
Holdings
Newest SOGC notifications: Amyra Biotech AG
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1006383647, Commercial Registry Office Basel-Stadt, (270)
Amyra Biotech AG, in Basel, CHE-321.956.288, Aktiengesellschaft (SHAB Nr. 164 vom 26.08.2024, Publ. 1006114055).
Statutenänderung:
15.11.2024. 02.07.2025.
Aktienkapital neu:
CHF 232'964.40 [bisher: CHF 222'496.92].
Liberierung Aktienkapital neu:
CHF 232'964.40 [bisher: CHF 222'496.92].
Aktien neu:
23'296'440 Namenaktien zu CHF 0.01 [bisher: 22'249'692 Namenaktien zu CHF 0.01]. Ordentliche Kapitalerhöhung innerhalb Kapitalband um CHF 10'467.48, wobei 27'748 Namenaktien zu CHF 0.01 durch Verrechnung von Forderungen in Höhe von CHF 60'770.00 liberiert werden. Die Gesellschaft hat mit Beschluss vom 15.11.2024 eine Erhöhung des bedingten Kapitals gemäss näherer Umschreibung in den Statuten beschlossen.
Publication number: HR02-1006114055, Commercial Registry Office Basel-Stadt, (270)
Amyra Biotech AG, in Basel, CHE-321.956.288, Aktiengesellschaft (SHAB Nr. 111 vom 11.06.2024, Publ. 1006053624).
Statutenänderung:
15.08.2024.
Aktienkapital neu:
CHF 222'496.92 [bisher: CHF 210'439.55].
Liberierung Aktienkapital neu:
CHF 222'496.92 [bisher: CHF 210'439.55].
Aktien neu:
22'249'692 Namenaktien zu CHF 0.01 [bisher: 21'043'955 Namenaktien zu CHF 0.01]. Ordentliche Kapitalerhöhung innerhalb Kapitalband um CHF 12'057.37, wobei 1'165'226 Namenaktien zu CHF 0.01 durch Verrechnung von Forderungen in Höhe von CHF 2'709'747.37 liberiert werden.
Publication number: HR02-1006053624, Commercial Registry Office Basel-Stadt, (270)
Amyra Biotech AG, in Basel, CHE-321.956.288, Aktiengesellschaft (SHAB Nr. 129 vom 06.07.2023, Publ. 1005788737).
Statutenänderung:
05.06.2024. [Streichung der Statutenbestimmung über die mit Ermächtigungsbeschluss vom 15.06.2022 eingeführte genehmigte Kapitalerhöhung.] [gestrichen: Die Generalversammlung hat mit Beschluss vom 15.06.2022 genehmigtes Aktienkapital gemäss näherer Umschreibung in den Statuten geschaffen.]. Kapitalband gemäss näherer Umschreibung in den Statuten.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.